• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation.

作者信息

Hijazi Ziad, Wallentin Lars

机构信息

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

出版信息

Heart. 2019 Mar;105(5):353-354. doi: 10.1136/heartjnl-2018-314040. Epub 2018 Oct 12.

DOI:10.1136/heartjnl-2018-314040
PMID:30314973
Abstract
摘要

相似文献

1
Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation.利钠肽应用作评估心房颤动患者的常规工具。
Heart. 2019 Mar;105(5):353-354. doi: 10.1136/heartjnl-2018-314040. Epub 2018 Oct 12.
2
Increased Cardiac Troponin T and N-Terminal B-Type Natriuretic Peptide in a 78-Year-Old Woman Admitted for Dizziness.一名因头晕入院的78岁女性患者，其心肌肌钙蛋白T和N末端B型利钠肽升高。
Clin Chem. 2017 Jan;63(1):435-436. doi: 10.1373/clinchem.2016.265603.
3
Post Cardiovascular Surgery Atrial Fibrillation. Biomarkers Determining Prognosis.心脏血管手术后心房颤动。生物标志物决定预后。
Curr Med Chem. 2019;26(5):916-924. doi: 10.2174/0929867324666170727104930.
4
The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.心房颤动患者中心钠肽前体 N 端（NT-proBNP）的心脏内浓度及其分泌的决定因素。
Kardiol Pol. 2018;76(2):433-439. doi: 10.5603/KP.a2017.0206. Epub 2017 Nov 13.
5
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.基于新型生物标志物的房颤卒中风险评分的性能和验证。
Circulation. 2016 Nov 29;134(22):1697-1707. doi: 10.1161/CIRCULATIONAHA.116.022802. Epub 2016 Aug 28.
6
Brain natriuretic peptide concentration in pericardial fluid is independently associated with atrial fibrillation after off-pump coronary artery bypass surgery.心包液中脑钠肽浓度与非体外循环冠状动脉搭桥术后房颤独立相关。
Coron Artery Dis. 2007 Jun;18(4):253-8. doi: 10.1097/MCA.0b013e328089f1b4.
7
Clinical Applications of Biomarkers in Atrial Fibrillation.生物标志物在心房颤动中的临床应用
Am J Med. 2017 Dec;130(12):1351-1357. doi: 10.1016/j.amjmed.2017.08.003. Epub 2017 Aug 16.
8
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).N 末端 B 型利钠肽前体在心房颤动患者风险评估中的应用：来自 ARISTOTLE 试验（阿哌沙班预防心房颤动患者卒中）的观察。
J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84. doi: 10.1016/j.jacc.2012.11.082. Epub 2013 Apr 3.
9
Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.利钠肽的血浆N末端片段可预测男性中风和心房颤动的风险。
Heart. 2009 Jul;95(13):1067-71. doi: 10.1136/hrt.2008.150342. Epub 2009 Mar 24.
10
Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation.用于心房颤动个性化卒中风险评估的生物标志物检测
Cardiovasc Hematol Disord Drug Targets. 2017;17(1):58-63. doi: 10.2174/1871529X17666170104120746.

引用本文的文献

1
Decreased plasma musclin levels are associated with potential atrial fibrillation in non-diabetic patients.血浆肌肉素水平降低与非糖尿病患者潜在的心房颤动有关。
Ann Transl Med. 2021 Feb;9(3):203. doi: 10.21037/atm-20-3259.
2
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.评估 ARISTOTLE 和 RE-LY 试验中联合应用阿司匹林和抗凝治疗的房颤患者的年龄、生物标志物和临床病史-出血风险评分。
JAMA Netw Open. 2020 Sep 1;3(9):e2015943. doi: 10.1001/jamanetworkopen.2020.15943.
3
Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels.
NT-proBNP水平筛查检测升高的75/76岁个体的临床和超声心动图特征。
Open Heart. 2020 Feb 19;7(1):e001200. doi: 10.1136/openhrt-2019-001200. eCollection 2020.
4
Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.利钠肽指导的治疗对无心力衰竭患者心血管事件的预防作用
Cochrane Database Syst Rev. 2019 Oct 15;10(10):CD013015. doi: 10.1002/14651858.CD013015.pub2.